Page last updated: 2024-09-03

sc 51089 and 8-epi-prostaglandin f2alpha

sc 51089 has been researched along with 8-epi-prostaglandin f2alpha in 1 studies

Compound Research Comparison

Studies
(sc 51089)
Trials
(sc 51089)
Recent Studies (post-2010)
(sc 51089)
Studies
(8-epi-prostaglandin f2alpha)
Trials
(8-epi-prostaglandin f2alpha)
Recent Studies (post-2010) (8-epi-prostaglandin f2alpha)
411191,863248723

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glaser, S; Hennerbichler, S; Juan, H; Sametz, W; Wintersteiger, R1

Other Studies

1 other study(ies) available for sc 51089 and 8-epi-prostaglandin f2alpha

ArticleYear
Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations.
    British journal of pharmacology, 2000, Volume: 130, Issue:8

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Bridged Bicyclo Compounds, Heterocyclic; Dinoprost; Dinoprostone; Dioxanes; Dose-Response Relationship, Drug; F2-Isoprostanes; Fatty Acids, Unsaturated; Female; Gastric Fundus; Guinea Pigs; Hydrazines; Ileum; In Vitro Techniques; Isoprostanes; Muscle Contraction; Muscle, Smooth; Oxazepines; Prostaglandin Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Thromboxane; Vasoconstriction; Vasoconstrictor Agents

2000